MedTrace Logo

Effectiveness of Malaria Camps as Part of the Odisha State Malaria Elimination Drive

NCT03963869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2463

Last updated 2022-01-11

No results posted yet for this study

Summary

The Odisha State Malaria Control Program (India) has introduced 'malaria camps' where teams of health workers visit villages to educate the population, enhance vector control with long-lasting insecticide nets (LLINs) and indoor residual spraying (IRS), and perform village-wide screening with rapid diagnostic tests and treatment for malaria. The long-term goal of this project is to evaluate the effectiveness of malaria camps (MCs) by determining if they reduce malaria, and to characterize malaria transmission in MCs.

Conditions

Interventions

OTHER

Malaria Camps

The Govt. of India Malaria Control Programme (MCP) of Odisha provides ITNs and IRS, and trains community health workers (ASHAs) on the diagnosis and treatment of malaria, providing them with antimalarial drugs so that malaria treatment is available even in remote villages. Faced with a persistent burden of malaria in forest villages, the MCP recently introduced malaria camps (MCs) combining focused screening and treatment in villages with intensified vector control. The program includes one round of testing and treatment for the whole village population before the monsoon season, followed by one round of screening and treating of fever cases only during the monsoon season.

Sponsors & Collaborators

  • Community Welfare Society Hospital

    collaborator UNKNOWN

  • Martin Luther Christian University

    collaborator UNKNOWN

  • Indian Institute of Public Health, India

    collaborator OTHER

  • National Institute of Research in Tribal Health

    collaborator UNKNOWN

  • National Vector Borne Disease Control Programme

    collaborator UNKNOWN

  • University Hospital, Umeå

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • New York University

    collaborator OTHER

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Jane Carlton, PhD · New York University

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-03
Primary Completion
2020-11-30
Completion
2021-03-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03963869 on ClinicalTrials.gov